Page 7 - Dalny Mine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dalny mine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dalny Mine Today - Breaking & Trending Today

Swiss National Bank Reduces Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Swiss National Bank lowered its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 10.5% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 400,600 shares of the biopharmaceutical company’s stock after selling 47,000 shares during the quarter. Swiss National Bank’s holdings […] ....

Michaelw Bonney , Alnylam Pharmaceuticals , Bessemer Group Inc , Quarter For Alnylam Pharmaceuticals , First Capital Advisors Group , Jpmorgan Chase Co , Alnylam Pharmaceuticals Company Profile , Capital Advisors Ltd , Cantor Fitzgerald , Swiss National Bank , Kb Financial Partners , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Stock Performance , Alnylam Pharmaceuticals Inc , V Square Quantitative Management , Free Report , National Bank , Square Quantitative Management , Director Michael , Visit Holdingschannel , Alnylam Pharmaceuticals Daily , Nasdaq Alny , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $170.00

Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective upped by JPMorgan Chase & Co. from $150.00 to $170.00 in a research report released on Thursday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also issued reports […] ....

New Zealand General , New Zealand , Michaelw Bonney , William Blair , Wells Fargo Company , Morgan Stanley , Wellington Management Group , Norges Bank , Alnylam Pharmaceuticals , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Inc , Jpmorgan Chase Co , Analyst Recommendations For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Price Performance , Capital International Investors , Institutional Trading Of Alnylam Pharmaceuticals , York Mellon Corp , Free Report , Moderate Buy , Get Free Report , Director Michael , International Investors , Management Group , Vance Management , New York Mellon Corp , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Acquired by Clearstead Advisors LLC

Clearstead Advisors LLC increased its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 197.6% during the third quarter, HoldingsChannel.com reports. The fund owned 4,518 shares of the biopharmaceutical company’s stock after buying an additional 3,000 shares during the period. Clearstead Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $800,000 at the end of […] ....

Michaelw Bonney , Alnylam Pharmaceuticals Inc , Daiwa Securities Group Inc , Wells Fargo Company , Clearstead Advisors , Insider Transactions At Alnylam Pharmaceuticals , Financial Services Group Inc , Alnylam Pharmaceuticals , Cantor Fitzgerald , Alnylam Pharmaceuticals Profile , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals Price Performance , Quarter For Alnylam Pharmaceuticals , Asset Management Inc , Vanguard Personalized Indexing Management , Free Report , Financial Advisors , Personalized Indexing Management , Securities Group , Management Inc , Services Group , Director Michael , Get Free Report , Visit Holdingschannel , Alnylam Pharmaceuticals Daily , Nasdaq Alny ,

Privium Fund Management B.V. Invests $3.55 Million in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Privium Fund Management B.V. acquired a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) in the 3rd quarter, Holdings Channel.com reports. The fund acquired 20,023 shares of the biopharmaceutical company’s stock, valued at approximately $3,546,000. Alnylam Pharmaceuticals accounts for about 1.1% of Privium Fund Management B.V.’s holdings, making the stock its […] ....

Piper Sandler , Sanfordc Bernstein , Michaelw Bonney , First Capital Advisors Group , News Ratings For Alnylam Pharmaceuticals Daily , V Square Quantitative Management , Morgan Stanley , Bessemer Group Inc , Alnylam Pharmaceuticals Company Profile , Alnylam Pharmaceuticals , Capital Advisors Ltd , Quarter For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Trading Down , Holdings Channel , Alnylam Pharmaceuticals Inc , Kb Financial Partners , Wells Fargo Company , Privium Fund Management , Free Report , Square Quantitative Management , Pharmaceuticals Trading Down , Get Free Report , Director Michael , Visit Holdingschannel , Alnylam Pharmaceuticals Daily , Nasdaq Alny ,

Nomura Asset Management Co. Ltd. Boosts Stock Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Nomura Asset Management Co. Ltd. lifted its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 68,017 shares of the biopharmaceutical company’s stock after purchasing an additional 1,804 shares during the quarter. […] ....

Michaelw Bonney , Sanfordc Bernstein , Piper Sandler , Quarter For Alnylam Pharmaceuticals , Capital International Investors , Nomura Asset Management Co , Needham Company , T Rowe Price Investment Management Inc , Alnylam Pharmaceuticals Inc , Alnylam Pharmaceuticals Stock Performance , Alnylam Pharmaceuticals Profile , Alnylam Pharmaceuticals , Securities Exchange Commission , News Ratings For Alnylam Pharmaceuticals Daily , Vanguard Group Inc , Blackrock Inc , Nomura Asset Management , Free Report , Asset Management , Rowe Price Investment Management , Street Corp , International Investors , Get Free Report , Director Michael , Exchange Commission , Visit Holdingschannel ,